Sartorius AG (XTER:SRT3) 3-Year Revenue Growth Rate : 42.70% (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG 3-Year Revenue Growth Rate?

Sartorius AG's Revenue per Share for the three months ended in Mar. 2024 was €11.84.

During the past 12 months, Sartorius AG's average Revenue per Share Growth Rate was -17.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 42.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 44.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 27.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Sartorius AG was 65.90% per year. The lowest was 0.50% per year. And the median was 9.60% per year.

Competitive Comparison of Sartorius AG's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Sartorius AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius AG's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Sartorius AG's 3-Year Revenue Growth Rate falls into.

Sartorius AG 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Sartorius AG (XTER:SRT3) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Sartorius AG 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Sartorius AG's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (XTER:SRT3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Executives

Dr. Joachim Kreuzburg

Board of Directors

Sartorius AG (XTER:SRT3) Headlines

No Headlines